A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk

Pre-clinical and epidemiologic studies provide rationale for evaluating lipophilic statins for breast cancer prevention. We conducted a single-arm, biomarker modulation trial of lovastatin among women with increased risk of breast cancer. Eligibility criteria included a deleterious germline mutation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Autores principales: Vinayak, Shaveta, Schwartz, Erich J., Jensen, Kristin, Lipson, Jafi, Alli, Elizabeth, McPherson, Lisa, Fernandez, Adrian M., Sharma, Vandana B., Staton, Ashley, Mills, Meredith A., Schackmann, Elizabeth A., Telli, Melinda L., Kardashian, Ani, Ford, James M., Kurian, Allison W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5508753/
https://ncbi.nlm.nih.gov/pubmed/24166281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2739-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares